BEAM 241220 30.00C (BEAM241220C30000) Stock Options, News & Quotes

US OptionsDetailed Quotes

BEAM241220C30000

Watchlist

0.42
0.000.00%

15min DelayClose Dec 13 16:00 ET

0.42High0.30Low

Intraday

5D
Daily

News

Editas Cut to Equal Weight by Wells Fargo Over Reni-cel Positioning
Seeking AlphaDec 11 17:18 ET
Why Beam Therapeutics (BEAM) Is the Worst ARK Stock to Buy According to Short Sellers
Yahoo FinanceDec 11 12:01 ET
A Quick Look at Today's Ratings for Beam Therapeutics(BEAM.US), With a Forecast Between $42 to $80
Moomoo NewsDec 10 08:00 ET · Ratings
Beam Therapeutics Price Target Maintained With a $80.00/Share by HC Wainwright & Co.
Dow JonesDec 9 12:49 ET · Ratings
Beam Therapeutics Analyst Ratings
BenzingaDec 9 12:37 ET · Ratings
Promising Early Data and Innovative Approaches Lead to Buy Rating for Beam Therapeutics
TipRanksDec 9 12:25 ET · Ratings

Comments

This_Guy

Dec 8 17:16

$Beam Therapeutics (BEAM.US)$
Beam Therapeutics Presents New Non-human Primate (NHP) Data Demonstrating Proof-of-concept for ESCAPE, a Non-genotoxic, Antibody-based Conditioning Approach to Treating Sickle Cell Disease, at American Society of Hematology (ASH) Annual Meeting
Beam Therapeutics (NASDAQ: BEAM) presented new data for its ESCAPE conditioning platform at the ASH Annual Meeting. The data demonstrated successful proof-of-concept in non-human primates (NHPs) for a non-genotoxic conditionin...

Moomoo News Global

Sep 10 08:28

Columns Here's What the Harris-Trump Debate Means for US Stocks

As the U.S. presidential election approaches in just two months, focus intensifies on the crucial debate between Vice President Kamala Harris and former President Donald Trump, scheduled for 9 p.m. ET on Tuesday, September 10. For investors strategizing around the "Trump trade" or the "Harris trade," the market's forward-looking reaction to their governing policies is critical. The election outcome will shape expectations of their administra...